BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25797752)

  • 1. Postmastectomy radiation for N2/N3 breast cancer: factors associated with low compliance rate.
    Chu QD; Caldito G; Miller JK; Townsend B
    J Am Coll Surg; 2015 Apr; 220(4):659-69. PubMed ID: 25797752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients.
    Shi Z; Peddi P; Burton G; Mills G; Shi R
    Anticancer Res; 2016 Jan; 36(1):261-9. PubMed ID: 26722052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.
    Shirvani SM; Pan IW; Buchholz TA; Shih YC; Hoffman KE; Giordano SH; Smith BD
    Cancer; 2011 Oct; 117(20):4595-605. PubMed ID: 21710653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
    Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
    Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
    Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmastectomy radiation and survival in older women with breast cancer.
    Smith BD; Haffty BG; Hurria A; Galusha DH; Gross CP
    J Clin Oncol; 2006 Oct; 24(30):4901-7. PubMed ID: 17050874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.
    Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.
    Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
    Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmastectomy Radiotherapy: Barriers to Implementation in a Disparate Population.
    Gan T; Huang B; Chen Q; McGrath PC; Evers BM; Marcinkowski EF
    Am Surg; 2020 Apr; 86(4):377-385. PubMed ID: 32391763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers.
    Francis SR; Frandsen J; Kokeny KE; Gaffney DK; Poppe MM
    Breast; 2017 Apr; 32():156-161. PubMed ID: 28193571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis.
    Ohri N; Sittig MP; Tsai CJ; Hwang ES; Mittendorf EA; Shi W; Zhang Z; Ho AY
    Cancer; 2018 Feb; 124(3):482-490. PubMed ID: 29112227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010.
    Wilke LG; Czechura T; Wang C; Lapin B; Liederbach E; Winchester DP; Yao K
    JAMA Surg; 2014 Dec; 149(12):1296-305. PubMed ID: 25390819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One decade later: trends and disparities in the application of post-mastectomy radiotherapy since the release of the American Society of Clinical Oncology clinical practice guidelines.
    Dragun AE; Huang B; Gupta S; Crew JB; Tucker TC
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e591-6. PubMed ID: 22768990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-free survival according to the use of postmastectomy radiation therapy after neoadjuvant chemotherapy.
    Nagar H; Boothe D; Ginter PS; Sison C; Vahdat L; Shin S; Smith M; Chao KS; Nori D; Hayes MK
    Clin Breast Cancer; 2015 Apr; 15(2):128-34. PubMed ID: 25459070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.